These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9629568)

  • 41. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute binge pattern cocaine administration induces region-specific effects in D1-r- and D2-r-expressing cells in eGFP transgenic mice.
    Lawhorn C; Edusei E; Zhou Y; Ho A; Kreek MJ
    Neuroscience; 2013 Dec; 253():123-31. PubMed ID: 24001687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone.
    Inoue O; Kobayashi K; Hosoi R; Yamaguchi M; Gee A
    J Neural Transm (Vienna); 1999; 106(11-12):1099-104. PubMed ID: 10651106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopaminergic and benzodiazepine receptors studied in vivo by PET.
    Hantraye P; Mazière B; Mazière M; Fukuda H; Naquet R
    J Physiol (Paris); 1986; 81(4):278-82. PubMed ID: 3033225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone.
    Logan J; Fowler JS; Dewey SL; Volkow ND; Gatley SJ
    J Neural Transm (Vienna); 2001; 108(3):279-86. PubMed ID: 11341479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma].
    Momose T; Teramoto A; Nishikawa J; Inoue Y; Watanabe T; Sasaki Y
    Kaku Igaku; 1993 Jun; 30(6):627-35. PubMed ID: 8345693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
    Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.
    Mateo Y; Lack CM; Morgan D; Roberts DC; Jones SR
    Neuropsychopharmacology; 2005 Aug; 30(8):1455-63. PubMed ID: 15702135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
    Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
    Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo studies of [125I]iodobenzamide and [11C]iodobenzamide: a ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D2 dopamine receptors.
    Wong DF; Wilson AA; Chen C; Minkin E; Dannals RF; Ravert HT; Sanchez-Roa P; Villemagne V; Wagner HN
    Synapse; 1992 Nov; 12(3):236-41. PubMed ID: 1481143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Striatal dopamine D2 receptor in Parkinson disease and its related disorders assessed by C-11 NMSP and PET].
    Momose T; Sasaki Y
    Nihon Rinsho; 1997 Jan; 55(1):227-32. PubMed ID: 9014455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C-N-methyl-spiperone.
    Eckernäs SA; Aquilonius SM; Hartvig P; Hägglund J; Lundqvist H; Någren K; Långström B
    Acta Neurol Scand; 1987 Mar; 75(3):168-78. PubMed ID: 3495092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of desipramine on dopamine receptor binding in vivo.
    Suhara T; Inoue O; Kobayasi K
    Life Sci; 1990; 47(23):2119-26. PubMed ID: 2266782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of chronic ethanol treatment and ethanol withdrawal on [3H]SCH23390 binding to rat striatal membranes.
    Gili-Martín E; Fernández-Briera A; Calvo P
    Neuropharmacology; 1997 Jan; 36(1):101-6. PubMed ID: 9144646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.
    Gunn RN; Lammertsma AA; Hume SP; Cunningham VJ
    Neuroimage; 1997 Nov; 6(4):279-87. PubMed ID: 9417971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
    Iyo M; Nishio M; Itoh T; Fukuda H; Suzuki K; Yamasaki T; Fukui S; Tateno Y
    Psychiatry Res; 1993 Dec; 50(4):217-31. PubMed ID: 8177922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cocaine uptake is decreased in the brain of detoxified cocaine abusers.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemannn R; Gatley SJ; MacGregor RR; Wolf AP
    Neuropsychopharmacology; 1996 Mar; 14(3):159-68. PubMed ID: 8866699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.